← stocks-llm New chat

Biogen (BIIB) — Congressional trading

Health Care

Biogen (BIIB) has 9 reported Congressional stock trading disclosures in our data, including 7 purchases and 2 sales among the most recent 9 (latest 2026-06-05).

Reported STOCK-Act stock transactions

Trade dateMemberTypeAmount rangeFiledSource
2026-06-05 Hon. Gilbert Cisneros Purchase $1,001 – $15,000 2026-07-02 PTR
2026-06-02 Hon. Maria Elvira Salazar Sale $15,001 – $50,000 2026-07-07 PTR
2026-05-12 Hon. Maria Elvira Salazar Purchase $1,001 – $15,000 2026-06-08 PTR
2026-05-11 Hon. Maria Elvira Salazar Purchase $50,001 – $100,000 2026-06-08 PTR
2026-05-11 Hon. Maria Elvira Salazar Purchase $1,001 – $15,000 2026-06-08 PTR
2026-01-30 Hon. Gilbert Cisneros Purchase $1,001 – $15,000 2026-02-13 PTR
2025-05-15 Hon. Rob Bresnahan Purchase $1,001 – $15,000 2025-06-09 PTR
2025-04-08 Hon. Rob Bresnahan Sale $1,001 – $15,000 2025-05-08 PTR
2025-02-25 Hon. Rob Bresnahan Purchase $1,001 – $15,000 2025-03-27 PTR

Ask the chat about Congressional trading in BIIB →

Source: U.S. House Clerk Periodic Transaction Reports (PTRs) filed under the STOCK Act. Disclosure can lag the actual trade by up to 45 days, so these are not real-time. Amounts are broad ranges as legally required — not exact figures. A transaction may belong to the member, their spouse, or a dependent child (see the owner column); a spouse or dependent trade is not the member's personal trade. This information is reused from the official public disclosure record for informational and public-interest (news) purposes only. Informational only — NOT financial advice, and NOT a signal to buy or sell.

See the full company profile: Biogen (BIIB).

Last updated 2026-06-05 (most recent disclosed transaction date).

Informational only — NOT financial advice. Congressional disclosures are sourced from the U.S. House Clerk public financial-disclosure archive and shown with their reported dates.